- Denali Therapeutics (NASDAQ:DNLI): Q2 GAAP EPS of -$0.56 beats by $0.04.
- More news on: Denali Therapeutics Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
2024-03-01 07:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-02-28 14:15:02 ET H.C. Wainwright analyst issues UNDERPERFORM recommendation for DNLI on February 28, 2024 02:00PM ET. The previous analyst recommendation was Underperform. DNLI was trading at $20.435 at issue of the analyst recommendation. The overall analyst conse...
Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings. Helix Energy posted ...